Can You Take Wegovy While Trying to Conceive?

Wegovy (semaglutide) is not recommended for women who are trying to conceive, pregnant, or breastfeeding — UK clinical guidance is consistent on this point.
Because semaglutide has a long half-life, prescribers advise stopping treatment at least two months before you plan to start trying, to allow adequate washout time.
Effective contraception is advised throughout treatment and during that washout period, your prescriber can help you plan both.
If you are already trying to conceive or think you may be pregnant, contact your prescriber promptly rather than simply stopping the medication yourself.

If you are trying to conceive, Wegovy (semaglutide) is not recommended. Current UK clinical guidance advises women to stop the medication before attempting pregnancy, because the safety of semaglutide in early conception is not established. This is not a bureaucratic footnote — it reflects a genuine gap in the evidence, and your prescriber needs to plan a safe stopping point with you well in advance. Wegovy is a prescription-only medicine, and any decision about timing must be made through a clinical assessment rather than on your own. The NHS England guidance on weight-management injections sets this out clearly for all GLP-1 medicines.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the guidance says, and how to time things safely if you plan to conceive

Step 1: Understand why Wegovy and conception don't overlap

There is a misconception that because GLP-1 medicines are not hormonal, they are broadly neutral for fertility and early pregnancy. That is not what the evidence shows. Semaglutide has not been adequately studied in women who are trying to conceive, and animal studies raised concerns that are taken seriously enough for regulators to recommend avoiding it during conception and pregnancy altogether. The NHS medicines page for semaglutide reflects this directly: the medicine is not recommended if you are pregnant, planning a pregnancy, or breastfeeding. Letting go of the idea that it is probably fine is the first step toward making a plan that actually protects you.

Beyond the question of direct risk, there is also the practical matter of weight stability. Stopping Wegovy often means appetite returns to baseline over several weeks. Building a nutritional foundation before conception (protein intake, folate, hydration) matters, and doing that while your appetite is adjusting requires some forethought. A prescriber can help you think through that transition, not just the stopping date itself.

For a broader look at how Wegovy interacts with pregnancy more generally, the page on Wegovy and pregnancy covers what is known and what remains uncertain in more detail.

Step 2: Plan a stopping date, not just a stopping intention

Semaglutide stays in the body for considerably longer than a weekly injection cycle might suggest. Its half-life is roughly one week, meaning meaningful concentrations persist for several weeks after the last dose. UK clinical guidance, including the NHS England weight-management injections guidance, advises stopping at least two months before you plan to start trying to conceive. That buffer accounts for both clearance time and the transition period your body needs.

Two months is a minimum working figure, not a guarantee. Your prescriber will look at your full clinical picture (how long you have been on treatment, your current dose, and your general health) before confirming a realistic stopping point. If you are on a higher maintenance dose, the conversation may lead to a slightly longer window. This is exactly the kind of question to raise at a clinical review rather than to estimate yourself.

Women on Wegovy who are not yet ready to conceive but are considering it in the next year or so should bring this up at their next review. Planning a year ahead is not overcautious; it gives you room to discuss contraception choices and to think about weight management in the post-treatment period. Our frequently asked questions page includes broader guidance on what to raise with a prescriber at a repeat review.

Step 3: Contraception during treatment and the washout period

Contraception matters on two levels here. First, becoming pregnant while actively taking Wegovy should be avoided, so reliable contraception throughout treatment is important. Second, that protection needs to continue into the washout period after stopping, so conception does not occur before semaglutide has adequately cleared.

There is an additional consideration specific to tirzepatide (Mounjaro) rather than semaglutide: the oral contraceptive pill may be absorbed less reliably during the early weeks of tirzepatide treatment. That specific interaction does not have the same established evidence base for semaglutide, but it is worth discussing your contraceptive method with your prescriber regardless of which GLP-1 medicine you take. If you are considering switching between the two, the page comparing semaglutide in pregnancy contexts gives useful background on how guidance differs across medicines in this class.

Questions about alcohol on treatment sometimes arise alongside fertility planning, and if you are wondering whether wine is safe during this period, the page on drinking wine while taking Wegovy addresses that directly and is worth reading alongside the broader guidance on drinking while on Wegovy during the period you are still on treatment.

What to do if your situation has already changed

If you are already trying to conceive and realise you have not yet stopped Wegovy, or if you think you may already be pregnant, contact your prescriber as soon as possible. Do not simply stop the medicine without speaking to a clinician first, particularly if you have been on it for some time. An abrupt stop rarely causes harm directly, but the follow-up (confirming early pregnancy, reviewing any other medicines, considering folic acid and dietary priorities) is best handled with clinical support rather than alone.

For the specific question of what happens if a pregnancy occurs while you are still on the medication, the page on taking Wegovy during pregnancy covers the evidence and recommended steps in full. The closely related question of Wegovy when trying to get pregnant looks at the pre-conception period from a slightly different angle and may be helpful if you are at an earlier planning stage.

If you are thinking about what weight management looks like after stopping treatment and before conceiving, or what options exist on the other side of pregnancy, a free consultation with our prescribers is a straightforward starting point. You can check your eligibility and start that conversation without any obligation. The treatment overview at our weight-loss page also sets out the options available for adults looking at the wider picture.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions